Human papillomavirus-type persistence patterns predict the clinical outcome of cervical intraepithelial neoplasia
- 1 September 2006
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 102 (3) , 517-522
- https://doi.org/10.1016/j.ygyno.2006.01.020
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The role of human papillomavirus testing in cervical screeningJournal of Clinical Virology, 2005
- Triage using HPV‐testing in persistent borderline and mildly dyskaryotic smears: Proposal for new guidelinesInternational Journal of Cancer, 2005
- Clinical relevance of human papillomavirus testing in cytopathologyCytopathology, 2005
- HPV triage of women with atypical squamous cells of undetermined significance: a 3-year experience in an Italian organized programmeCytopathology, 2005
- Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smearsGynecologic Oncology, 2004
- Triage with human papillomavirus testing of women with cytologic abnormalities prompting referral for colposcopy assessmentCancer, 2004
- No confirmed case of human papillomavirus DNA-negative cervical intraepithelial neoplasia grade 3 or invasive primary cancer of the uterine cervix among 511 patientsAmerican Journal of Obstetrics and Gynecology, 2003
- Factors associated with an increased risk of prevalent and incident grade III cervical intraepithelial neoplasia and invasive cervical cancer among women with Papanicolaou tests classified as grades I or II cervical intraepithelial neoplasiaAmerican Journal of Obstetrics and Gynecology, 2002
- HPV DNA Testing in Cervical Cancer ScreeningJAMA, 2000
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999